On 3 December FDA released their draft guideline on immunogenicity testing on their website:
Guidance for Industry: Assay Development for Immunogenicity Testing of Therapeutic Proteins
The consultation period is 60 days.
Thursday, December 10, 2009
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment